Cargando…
The role of CCR1 and therapeutic effects of anti‐CCL3 antibody in herpes simplex virus‐induced Behçet's disease mouse model
Behçet's disease (BD) is a chronic systemic inflammatory disease with unclear etiopathogenesis. Although gene variants of CC chemokine receptor type 1 (CCR1) have been reported, the protein expression of CCR1 in patients with BD remains unclear. The objective of this study was to analyze the fr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797864/ https://www.ncbi.nlm.nih.gov/pubmed/31393598 http://dx.doi.org/10.1111/imm.13102 |
_version_ | 1783459929761251328 |
---|---|
author | Sayeed, Hasan M. Lee, Eun‐So Byun, Hae‐Ok Sohn, Seonghyang |
author_facet | Sayeed, Hasan M. Lee, Eun‐So Byun, Hae‐Ok Sohn, Seonghyang |
author_sort | Sayeed, Hasan M. |
collection | PubMed |
description | Behçet's disease (BD) is a chronic systemic inflammatory disease with unclear etiopathogenesis. Although gene variants of CC chemokine receptor type 1 (CCR1) have been reported, the protein expression of CCR1 in patients with BD remains unclear. The objective of this study was to analyze the frequencies of CCR1(+) cells in a herpes simplex virus‐induced mouse model of BD. The frequencies of CCR1(+) cells on the surface and in the cytoplasm of peripheral blood mononuclear cells and lymph nodes were analyzed by flow cytometry. The CCR1(+) cells were significantly down‐regulated in BD mice compared with the normal control and symptom‐free control mice. Colchicine and pentoxifylline treatment improved the symptoms of BD and increased the frequencies of CCR1(+) cells in BD mice. Treatment with chemokine CC motif ligand 3 (CCL3), a ligand of CCR1, caused BD symptoms to deteriorate in 10 of 16 BD mice (62·5%) via down‐regulation of CCR1(+) cells. Anti‐CCL3 antibody treatment ameliorated BD symptoms in 10 of 20 mice (50%) and significantly decreased the disease severity score compared with CCL3‐treated BD mice (P = 0·01) via up‐regulation of CCR1(+) cell frequencies. In patients with BD, plasma levels of CCL3 in an active state were significantly higher than in healthy control individuals (P = 0·02). These results show that the up‐regulation of CCR1(+) cells was related to the control of systemic inflammation of BD in mouse models. |
format | Online Article Text |
id | pubmed-6797864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67978642020-04-21 The role of CCR1 and therapeutic effects of anti‐CCL3 antibody in herpes simplex virus‐induced Behçet's disease mouse model Sayeed, Hasan M. Lee, Eun‐So Byun, Hae‐Ok Sohn, Seonghyang Immunology Original Articles Behçet's disease (BD) is a chronic systemic inflammatory disease with unclear etiopathogenesis. Although gene variants of CC chemokine receptor type 1 (CCR1) have been reported, the protein expression of CCR1 in patients with BD remains unclear. The objective of this study was to analyze the frequencies of CCR1(+) cells in a herpes simplex virus‐induced mouse model of BD. The frequencies of CCR1(+) cells on the surface and in the cytoplasm of peripheral blood mononuclear cells and lymph nodes were analyzed by flow cytometry. The CCR1(+) cells were significantly down‐regulated in BD mice compared with the normal control and symptom‐free control mice. Colchicine and pentoxifylline treatment improved the symptoms of BD and increased the frequencies of CCR1(+) cells in BD mice. Treatment with chemokine CC motif ligand 3 (CCL3), a ligand of CCR1, caused BD symptoms to deteriorate in 10 of 16 BD mice (62·5%) via down‐regulation of CCR1(+) cells. Anti‐CCL3 antibody treatment ameliorated BD symptoms in 10 of 20 mice (50%) and significantly decreased the disease severity score compared with CCL3‐treated BD mice (P = 0·01) via up‐regulation of CCR1(+) cell frequencies. In patients with BD, plasma levels of CCL3 in an active state were significantly higher than in healthy control individuals (P = 0·02). These results show that the up‐regulation of CCR1(+) cells was related to the control of systemic inflammation of BD in mouse models. John Wiley and Sons Inc. 2019-09-08 2019-11 /pmc/articles/PMC6797864/ /pubmed/31393598 http://dx.doi.org/10.1111/imm.13102 Text en © 2019 John Wiley & Sons Ltd |
spellingShingle | Original Articles Sayeed, Hasan M. Lee, Eun‐So Byun, Hae‐Ok Sohn, Seonghyang The role of CCR1 and therapeutic effects of anti‐CCL3 antibody in herpes simplex virus‐induced Behçet's disease mouse model |
title | The role of CCR1 and therapeutic effects of anti‐CCL3 antibody in herpes simplex virus‐induced Behçet's disease mouse model |
title_full | The role of CCR1 and therapeutic effects of anti‐CCL3 antibody in herpes simplex virus‐induced Behçet's disease mouse model |
title_fullStr | The role of CCR1 and therapeutic effects of anti‐CCL3 antibody in herpes simplex virus‐induced Behçet's disease mouse model |
title_full_unstemmed | The role of CCR1 and therapeutic effects of anti‐CCL3 antibody in herpes simplex virus‐induced Behçet's disease mouse model |
title_short | The role of CCR1 and therapeutic effects of anti‐CCL3 antibody in herpes simplex virus‐induced Behçet's disease mouse model |
title_sort | role of ccr1 and therapeutic effects of anti‐ccl3 antibody in herpes simplex virus‐induced behçet's disease mouse model |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797864/ https://www.ncbi.nlm.nih.gov/pubmed/31393598 http://dx.doi.org/10.1111/imm.13102 |
work_keys_str_mv | AT sayeedhasanm theroleofccr1andtherapeuticeffectsofanticcl3antibodyinherpessimplexvirusinducedbehcetsdiseasemousemodel AT leeeunso theroleofccr1andtherapeuticeffectsofanticcl3antibodyinherpessimplexvirusinducedbehcetsdiseasemousemodel AT byunhaeok theroleofccr1andtherapeuticeffectsofanticcl3antibodyinherpessimplexvirusinducedbehcetsdiseasemousemodel AT sohnseonghyang theroleofccr1andtherapeuticeffectsofanticcl3antibodyinherpessimplexvirusinducedbehcetsdiseasemousemodel AT sayeedhasanm roleofccr1andtherapeuticeffectsofanticcl3antibodyinherpessimplexvirusinducedbehcetsdiseasemousemodel AT leeeunso roleofccr1andtherapeuticeffectsofanticcl3antibodyinherpessimplexvirusinducedbehcetsdiseasemousemodel AT byunhaeok roleofccr1andtherapeuticeffectsofanticcl3antibodyinherpessimplexvirusinducedbehcetsdiseasemousemodel AT sohnseonghyang roleofccr1andtherapeuticeffectsofanticcl3antibodyinherpessimplexvirusinducedbehcetsdiseasemousemodel |